CONGENITAL NEPHROTIC SYNDROME: A CASE REPORT

Abstract
Congenital nephrotic syndrome (CNS) is a rare kidney disorder characterized by severe protein urea, hypo-protein aemia, and edema commencing shortly after birth. The majority CNS type often discovered is Finnish by common indication of prematurely born infant with a large placenta. Prenatal diagnosis can be through the detection of high levels of Alfa fetoprotein in the amniotic fluid. The infant aged one month 18 days had abdominal swelling that was noticeable from 21 days after birth. The infant hospitalized at Kolaka Hospital had anasarca edema, hypo-albuminemia (albumin 1.0 g / dl), protein urea (+++), and hyper-lipidaemia (209). Patient’s history of receiving albumin transfusions. Referring to the anamnesis and physical examination, the infant endured a CNS started less than three months after birth, and the onset factor of symptoms led to primary CNS due to genetic disorders.
The diagnosis is made based on history, physical examination, and supporting investigations. The patient accepts the treatment of intravenous albumin transfusion followed by intravenous antibiotics for secondary infection.
Keywords
Congenital, Nephrotic syndrome, Child Health.How to Cite
References
Albar,H. and Bilondatu,F.. Profile of Pediatric Nephrotic Syndrome in Wahidin Sudirohusodo Hospital, Makassar, Indonesia. 2019. CDK-274/ vol. 46, No. 3
Mishra,O.P.et al. Can We Predict Relapses in Children with Idiopathic Steroid-Sensitive Nephrotic Syndrome.India. Journal Of Tropical Pediatric.2013; Vol. 59, No. 5
Kher,K.K .Clinical Pediatric Nephrology: Nephrotic Syndrome 3rded.CRC Press.2017;pp.286-97
Uwaezuoke,S.N.Steroid-sensitive nephrotic syndrome in children: triggers of relapse and evolving hypotheses on pathogenesis. Italian Journal of Pediatrics .2015;41:19 DOI 10.1186/s13052-015-0123-9
Willicombe,M.Thomas,D. and McAdoo,S.COVID-19 and Calcineurin Inhibitors: Should They Get Left Out in the Storm?.JASN.2020; doi:
https://doi.org/10.1681/ASN.2020030348
Lotfi,B ,Farshid.S, Dadashzadeh.N, Valizadeh.R, and Mohsen.R. Is Coronavirus Disease 2019(COVID-19) Associated with Renal Involvement A Review of Century Infection. Jandishapur J Microbiol.2020.doi:10.5812/jjm.102899
The Jakarta post. Indonesia's latest official COVID-19 figures.https://www.thejakartapost.com/news/2020/03/23/indonesias-latest-covid-19-figures.html. Accessed 20 May 2020.
Liu,B.Li,M. Zhoua,Z. Guane,X. Xiang,Y. Can we use interleukin-6 (IL-6) blockade for coronavirus disease 2019 (COVID-19)-induced cytokine release syndrome(CRS).Journal of Autoimmunity. 2019. https://doi.org/10.1016/j.jaut.2020.102452
Al Eisa, et al. Urinary excretion of IL-1β, IL-6 and IL-8 cytokines during relapse and remission of idiopathic nephrotic syndrome. Journal of Inflammation Research.2017;10
Vaduganathan, M.et al. Renin-Angiotensin-Aldosterone-System Inhibitor in Patient with Covid-19. The New England Journal Medicine.2020; pp 1653-59
Su H, Lei C-T and Zhang C. Interleukin-6 Signaling Pathway and Its Role in Kidney Disease: An update. Front. Immunol. 2017;8:405. doi: 10.3389/fimmu.2017.00405
Askanase, AD.Khalili,L.Buyon,JP. Thoughts COVID-19 and Autoimmune Diseases. Lupus Science and Medicine.2020.doi:10.1136/lupus-2020-000396
Gandhi,RT,et al. Mild or Moderate. New England Journal of Medicine.2020. doi: 10.1056/NEJMcp2009249
Lang, AD. Osterhaus,A, D.M.E. Haagmans,B.L. Interferon-γ and interleukin-4 downregulate expression of the SARS coronavirus receptor ACE2 in Vero E6 cells. Elsevier Inc. Virology 353 (2006) 474 –481. doi:10.1016/j.virol.2006.06.011
Ciaglia,E.Vecchione,C. Puca,AA. COVID-19 Infection and Circulating ACE-2 Levels: Protective Role in Women and Children. Front.Pediatric.2020;8:206.doi : 10.3389/fped.2020.00206
Shi,Yufang.et al. COVID-19 infection: the perspectives on immune responses.Cell Death & Differentiation. 2020; 27:14511454.https://doi.org/10.1038/s41418-020-0530-3
Marietta, Marco.et al. COVID-19 and hemostasis: a position paper from Italian Society on Thrombosis and Haemostasis (SISET). Blood Transfus2020; DOI 10.2450/2020.0083-20
Hardenberg, job.Favaloro, Emmanuel.COVID-19: progression of the disease and intravascular coagulation – present status and future perspectives. : Department of Hematology, Sydney Centers for Thrombosis and Hemostasis, Institute of Clinical Pathology and Medical Research, NSW Health Pathology, Westhead Hospital, Westmeath, New South Wales, Australia.2020; https://doi.org/10.1515/cclm-2020-0502
Connors, Jean. Levy, Jerrold. COVID-19 and its implications for thrombosis and anticoagulation. American Society of Hematology.2020
London Real Army. Interview with Dr. Andrew Kaufman - UNMASKING THE LIES AROUND COVID-19. 2020. Available from : https://anchor.fm/londonrealarmy/support
License
Copyright (c) 2022 Dr. ERNI MURDANINGSIH, Dr. SYARIFUDDIN RAUF , Dr. JUSLI ARAS

This work is licensed under a Creative Commons Attribution 4.0 International License.
Individual articles are published Open Access under the Creative Commons Licence: CC-BY 4.0.